The woman's family’s lawsuit was the third product-liability case to go to trial over the bone-strengthening treatments. Last month, a New Jersey jury rejected a woman’s claims that Aredia and Zometa caused her jaw deterioration. In October 2009, a Montana jury ordered Novartis to pay $3.2 million in damages to a cancer patient who made the same claims over the medicines.
Novartis is facing about 700 suits over the bone-strengthening medicines, according to court filings. Some of the cases have been consolidated before a federal judge in Tennessee. Others have been sent back to their home courts for trial. Still other cases have been heard in state courts around the country.
Our Zometa/Aredia cases are currently still consolidated in the MDL awaiting transfer for trial.